The Toyota Audio Multimedia infotainment system, now used throughout most of the Toyota lineup, comes standard in every 2026 ...

Emerging aviation technologies developer Aurora Flight Sciences is progressing with assembly of its prototype X-65 active flow control demonstrator. Aurora on 20 November shared an image of the X-65 ...

AUSTIN, Texas--(BUSINESS WIRE)--Allen Control Systems (ACS), a leader in autonomous precision robotics, today announced the release of Treillis, its next-generation Hardware-in-the-Loop (HIL) test ...

As Democrat Mikie Sherrill handily defeated Republican Jack Ciattarelli in New Jersey’s bitterly contested gubernatorial race Tuesday, she also learned she’ll work with a state Legislature where both ...

Rollercoaster Tycoon wasn’t the most fashionable computer game out there in 1999. But if you took a look beneath the pixels—the rickety rides, the crowds of hungry, thirsty, barfing people (and the ...

When a multi-die package worth $500 fails final test because of a defect that originated three process steps earlier, the economics of advanced packaging become painfully clear. Each excursion carries ...

FIRST ON FOX: For the first time, U.S. fighter pilots took direction from an AI "air battle manager" in a Pentagon test that could change how wars are fought in the skies. The Air Force and Navy ran ...

The California State Assembly chamber in Sacramento. (File photo courtesy of the Sergeant at Arms) Sacramento is once again moving to dictate how cities operate. This time through Assembly Bill 339, a ...

With artificial intelligence (AI) causing a surge in electricity demand across the world, power capacity and availability are more vital than ever. The race is on to build more generation assets. In ...

An experimental birth control pill for males works by blocking sperm production, and it just passed its first safety test in humans. When you purchase through links on our site, we may earn an ...

A hormone-free pill, called YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite has just concluded its first safety trial in humans, getting a step closer to increasing ...